We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $3.89B
1-Year Est. Return 16.15%
This Fund
S&P 500
This Quarter Est. Return
-9.26%
1 Year Est. Return
+16.15%
3 Year Est. Return
+48.47%
5 Year Est. Return
+55.5%
10 Year Est. Return
+378.36%
AUM
$19.3B
AUM Growth
-$2.78B
Cap. Flow
-$399M
Cap. Flow %
-2.06%
Top 10 Hldgs %
19.12%
Holding
149
New
4
Increased
70
Reduced
65
Closed
8

Top Buys

Rank Stock Value
1
IEX icon
IDEX
IEX
+$65M
2
DXCM icon
DexCom
DXCM
+$63M
3
ASAN icon
Asana
ASAN
+$62.2M
4
ROK icon
Rockwell Automation
ROK
+$53.5M
5
WSFS icon
WSFS Financial
WSFS
+$51.3M

Top Sells

Rank Stock Value
1
HSY icon
Hershey
HSY
+$171M
2
STE icon
Steris
STE
+$111M
3
PLAN
Anaplan, Inc.
PLAN
+$98.1M
4
CRNC icon
Cerence
CRNC
+$86.6M
5
TMX
Terminix Global Holdings, Inc.
TMX
+$82.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.15%
2 Technology 22.95%
3 Industrials 17.41%
4 Financials 13.37%
5 Consumer Staples 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROCK icon
126
Gibraltar Industries
ROCK
$1.33B
$33M 0.17%
769,200
-36,830
-5% -$1.94M
TRNS icon
127
Transcat
TRNS
$757M
$32.6M 0.17%
401,825
+73,690
+22% +$5.99M
WASH icon
128
Washington Trust Bancorp
WASH
$763M
$26.6M 0.14%
506,610
-248,350
-33% -$13.9M
VAPO
129
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$20.9M 0.11%
187,899
-3,460
-2% -$432K
EWCZ
130
DELISTED
European Wax Center
EWCZ
$17.9M 0.09%
605,995
+500,325
+473% +$13M
HNST icon
131
The Honest Company
HNST
$586M
$12.7M 0.07%
2,438,785
-110,275
-4% -$664K
CCF
132
DELISTED
Chase Corporation
CCF
$12.4M 0.06%
142,485
-137,325
-49% -$12.7M
ZVIA icon
133
Zevia
ZVIA
$93.8M
$8.81M 0.05%
1,927,085
-14,585
-0.8% -$102K
ARCE
134
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$1.42M 0.01%
67,510
+4,835
+8% +$94.4K
CINT icon
135
CI&T Inc
CINT
$408M
$1.33M 0.01%
83,190
-6,760
-8% -$98.9K
FRSH icon
136
Freshworks
FRSH
$3.27B
$993K 0.01%
+55,440
New +$1.13M
VTEX icon
137
VTEX
VTEX
$605M
$976K 0.01%
158,655
+66,975
+73% +$499K
API
138
Agora
API
$331M
$424K ﹤0.01%
42,665
+105
+0.2% +$1.18K
DADA
139
DELISTED
Dada Nexus
DADA
$407K ﹤0.01%
44,600
MELI icon
140
Mercado Libre
MELI
$93.5B
$275K ﹤0.01%
231
NOW icon
141
ServiceNow
NOW
$149B
$228K ﹤0.01%
2,050
+250
+14% +$28K
AVNS
142
DELISTED
Avanos Medical
AVNS
-1,174,483
Closed -$40.7M
BNR
143
Burning Rock Biotech
BNR
$124M
-2,834
Closed -$270K
CRNC icon
144
Cerence
CRNC
$370M
-1,130,570
Closed -$86.6M
EPAM icon
145
EPAM Systems
EPAM
$6.45B
-300
Closed -$201K
HSY icon
146
Hershey
HSY
$34.4B
-881,490
Closed -$171M
NVST icon
147
Envista
NVST
$4.02B
-813,855
Closed -$36.7M
PBH icon
148
Prestige Consumer Healthcare
PBH
$2.27B
-849,435
Closed -$51.5M
BMTC
149
DELISTED
Bryn Mawr Bank Corp
BMTC
-1,018,050
Closed -$45.8M

Similar funds

Champlain Investment Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Champlain Investment Partners held 149 positions worth $19.3B, down 13% from $22.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners's Q1 2022 filing shows 4 new, 70 increased, 65 reduced and 8 closed positions. Its largest new stake was DexCom: 576,320 shares worth $73.7M. The largest sale was Hershey, an estimated $171M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q1 2022 buy was DexCom: 576,320 shares worth $73.7M.
  • Champlain Investment Partners added most to IDEX in Q1 2022, an estimated $65M increase.
  • Champlain Investment Partners's biggest Q1 2022 reduction was Steris, cutting an estimated $111M.
  • Champlain Investment Partners fully exited Hershey in Q1 2022, selling an estimated $171M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $19.3B portfolio in Q1 2022.
  • Champlain Investment Partners opened 4 new positions and closed 8 in Q1 2022.
  • Champlain Investment Partners's portfolio value fell 13% quarter-over-quarter to $19.3B.

Based on Champlain Investment Partners's 13F filing for Q1 2022, filed 12 May 2022.